Colifagina, a Novel Preparation of 8 Lysed Bacteria Ameliorates Experimental Colitis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  International Journal of Immunopathology and Pharmacology

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/039463200802100219PMID 18547485
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.

  2007cited by this paper
• Probiotics and inflammatory bowel diseases

  2006cited by this paper
• The Composition of Intestinal Bacteria Affects the Level of Luminal IgA

  2006cited by this paper
• Probiotics and prebiotics in chronic inflammatory bowel diseases.

  2006cited by this paper
• Probiotic Therapy in the Prevention of Pouchitis Onset: Decreased Interleukin‐1&bgr;, Interleukin‐8, and Interferon‐&ggr; Gene Expression

  2005cited by this paper
• Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression.

  2005cited by this paper
• VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

  2005cited by this paper
• Lactobacillus GG in inducing and maintaining remission of Crohn's disease

  2004cited by this paper
• Host-bacterial interactions in inflammatory bowel disease.

  2004cited by this paper
• Lactobacillus GG bacteria ameliorate arthritis in Lewis rats.

  2004cited by this paper
• Lactobacillus rhamnosus GG decreases TNF‐α production in lipopolysaccharide‐activated murine macrophages by a contact‐independent mechanism

  2003cited by this paper
• Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG

  2002cited by this paper
• A dietary probiotic (Bifidobacterium lactis HN019) reduces the severity of Escherichia coli O157:H7 infection in mice

  2001cited by this paper
• Probiotics: effects on immunity.

  2001cited by this paper
• Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice

  2000cited by this paper
• Probiotic immunomodulation in health and disease.

  2000cited by this paper
• Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.

  1999cited by this paper
• Promotion of IgA immune response in patients with Crohn's disease by oral bacteriotherapy with Lactobacillus GG.

  1996cited by this paper
• GASTROENTEROLOGY 2006;130:2060–2073 Angiogenesis as a Novel Component of Inflammatory Bowel Disease Pathogenesis

  year unknowncited by this paper

• Intestinal Inflammation and Mucosal Barrier Function

  2014cites this paper
• Intravenous Administration of High-Dose Paclitaxel Reduces Gut-Associated Lymphoid Tissue Cell Number and Respiratory Immunoglobulin A Concentrations in Mice

  2014cites this paper
• Stimulation of nitric oxide, cytokine and prostaglandin production by low-molecular weight fractions of probiotic Lactobacillus casei lysate.

  2012cites this paper
• Efficacy of an enterovaccine in recurrent episodes of diarrhea in the dog: a pilot study.

  2012cites this paper
• Nutritional and Probiotic Supplementation in Colitis Models

  2012cites this paper
• Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.

  2010cites this paper
• Recent developments and perspectives in the investigation of probiotic effects.

  2010cites this paper
• Innate Immunity and Microbes: Conversations with the Gut Leading to Intestinal Tissue Repair and Fibrosis

  2009cites this paper
• Improvement of functional bloating by an enterovaccine: a preliminary study.

  2009cites this paper
• IL-32: a newly-discovered proinflammatory cytokine.

  2009cites this paper